TC Energy Corp
TRP
Brookfield Renewable Partners LP
BEP.UN
Bank of Nova Scotia
BNS
4
The Toronto-Dominion Bank
TD
5
Enbridge Inc
ENB
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.